Samuel S. Ahn, MD, David E. Williams, BA, Dirk A

Slides:

Advertisements

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Advertisements

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers David L. Steed, MD, the.

Heparin-coated catheters and heparin-induced thrombocytopenia

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease Samuel R. Money, MD, J.Alan.

Richard T. Purdy, M. D. , Frederick C. Beyer, M. D. , William D

Creation and closure of temporary arteriovenous fistulas for venous reconstruction or thrombectomy: Description of technique Richard J. Sanders, M.D.,

Surgical management of infected abdominal aortic grafts: Review of a 25-year experience Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,

A new valvulotome for in situ bypass grafts

Computed electroencephalographic topographic brain mapping

Jeffrey R. Rubin, M.D., James M. Malone, M.D., Jerry Goldstone, M.D.

Axillofemoral bypass: A tool with a limited role

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease Samuel R. Money, MD, J.Alan.

Malcolm O. Perry, MD, Richard Kempczinski, MD

Recurrent thoracic outlet syndrome

The management of massive ultrafiltration distending the aneurysm sac after abdominal aortic aneurysm repair with a polytetrafluoroethylene aortobiiliac.

Antibacterial activity, antibiotic retention, and infection resistance of a rifampin- impregnated gelatin-sealed Dacron graft Kevin Lachapelle, MD, Alan.

Heparin-coated catheters and heparin-induced thrombocytopenia

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Objective tinnitus resulting from internal carotid artery stenosis

Physiology of carotid endarterectomy with ocular pneumoplethysmography

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

David L. Dawson, MD, Jennifer Meyer, RCIS, Eugene S

Recreational weight lifting and aortic dissection: Case report

Calvin B. Ernst, MD Journal of Vascular Surgery

Ruptured abdominal aortic aneurysm: A population-based study

Mesenteric blood flow in patients with diabetic neuropathy

Linda M. Reilly, M. D. , Ronald J. Stoney, M. D. , Jerry Goldstone, M

Results of six hundred thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices Mitsuo Sugiura,

Cardiovascular surgery—The rocket and its stars: Presidential address

William B. Shue, BA †, Sharon C. Worosilo, MS, Anthony P

The fate of the donor artery in extraanatomic revascularization

Composite sequential bypasses to the ankle and beyond for limb salvage

Dipankar Mukherjee, M. D. , William J. Schickler, M. D

Research and research funding in vascular surgery

J.Dennis Baker, MD Journal of Vascular Surgery

Endotoxemia after major vascular operations

Regional nerve block for femoropopliteal and tibial arterial reconstructions Joseph M. Giordano, M.D., George A. Morales, M.D., Hugh H. Trout, M.D., Ralph.

William C. Krupski, MD, Elizabeth L. Layug, MD, Linda M

Septic embolism complicating infective endocarditis

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Isolated profundaplasty for limb salvage

Richard J. Sanders, MD 1, William H. Pearce, MD 2

Should patient age be a consideration in carotid endarterectomy?

Acute aortic occlusion – Factors that influence outcome

Exposure of femoral vessels by a suprainguinal incision

Monitoring vascular surgical performance

Toe pressure determination by audiophotoplethysmography

Glenn C. Hunter, M.D., Stan N. Carson, M.D.

Salvage of exposed arteriovenous hemodialysis fistulas

D. Emerick Szilagyi, MD—An appreciation

Presidential address: The second-generation vascular surgeon

George D. Lilly 1906–1988 Journal of Vascular Surgery

James A. DeWeese, MD Journal of Vascular Surgery

Mid-term results of a second generation bifurcated endovascular graft for abdominal aortic aneurysm repair: The French Vanguard trial Jean-Pierre Becquemin,

Jerry Goldstone, MD Journal of Vascular Surgery

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Innominate artery trauma: A thirty-year experience

Popliteal entrapment syndrome: A report of tibial nerve entrapment

Lower extremity lymphedema caused by acquired immune deficiency syndrome – related Kaposi's sarcoma: Case report and review of the literature Peter J.

Expansion rates and outcomes for iliac artery aneurysms

Supraclavicular reoperation for neurogenic thoracic outlet syndrome

Thigh claudication due to profunda femoris artery occlusion

Lessons learned in adopting the in situ saphenous vein bypass

Endovascular repair of two abdominal aortic aneurysms

Optimal proximal anastomosis/tunnel for axillofemoral grafts

Cornelius A. Sullivan, MD, Michael J. Rohrer, MD, Bruce S. Cutler, MD

Presentation transcript:

The isolation of a fibroblast growth inhibitor associated with perigraft seroma Samuel S. Ahn, MD, David E. Williams, BA, Dirk A. Thye, BA, Karen Qi Cheng, PhD, David A. Lee, MD Journal of Vascular Surgery Volume 20, Issue 2, Pages 202-208 (August 1994) DOI: 10.1016/0741-5214(94)90007-8 Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 1 A, Fibroblast growth response to increasing concentrations of normal human serum (NHS), serum from patient with perigraft seroma around PTFE axillo-femoral graft (PGS I), serum from patient with perigraft seroma around PTFE femoropopliteal graft (PGS II) and serum from this latter patient 6 months after graft removal and seroma resolution. Measured by [3H] thymidine assay. B, Fibroblast growth response with same serum samples as described in Fig. 1, A. Measured by hexosaminidase colorimetric assay. Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 1 A, Fibroblast growth response to increasing concentrations of normal human serum (NHS), serum from patient with perigraft seroma around PTFE axillo-femoral graft (PGS I), serum from patient with perigraft seroma around PTFE femoropopliteal graft (PGS II) and serum from this latter patient 6 months after graft removal and seroma resolution. Measured by [3H] thymidine assay. B, Fibroblast growth response with same serum samples as described in Fig. 1, A. Measured by hexosaminidase colorimetric assay. Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 2 Fibroblast growth response to 50% test serum with same samples as described in Fig. 1, A. Measured by [3H] thymidine assay. Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 3 Fibroblast growth response to PGS II fractions at 20% of well volume. Measured with [3H] thymidine assay Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 4 Fibroblast growth response to normal human serum fractions at 20% of well volume. Measured with [3H] thymidine assay. Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 5 Fibroblast growth response to uninfected and infected graft serum fractions at 50% of well volume. Measured with [3H] thymidine assay. Journal of Vascular Surgery 1994 20, 202-208DOI: (10.1016/0741-5214(94)90007-8) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions